Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

61302

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which GP practices have been identified by NHS England as potentially losing more than £3 per patient in 2014-15 following the withdrawal of the Minimum Practice Income Guarantee.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	200213
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>NHS England has published an anonymised list of ‘outliers' which can be found at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2014/02/gp-gms-practices.pdf</p><p> </p><p>Because the information is commercially sensitive, details that could identify individual practices have not been released.</p><p> </p><p>The Minimum Practice Income Guarantee is being phased out over a period of seven years because it is inequitable, and the money released will be reinvested into basic payments made to all General Medical Services practices.</p><p><strong> </strong></p><p>NHS England is supporting the most affected practices.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 13:40:30 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1506 label Biography information for Andrew Gwynne

61303

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of being able to access a GP appointment within 48 hours on levels of patient satisfaction.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	200214
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>Overall patient satisfaction is driven by a range of factors, including accessing a general practitioner (GP) appointment at a convenient time, ability to see a preferred GP and the quality of the conversation with the GP.</p><p> </p><p>The Government recognises the importance of timely access to general practice. The PM Challenge Fund has allocated £50 million to pilot ways to improve access around the country, to give GPs the flexibility to meet the needs of the local population.</p><p> </p><p>In addition, the new GP contract introduced a new Enhanced Service, which includes a commitment to same day phone consultations with a professional in the GP surgery, where necessary, for the most at risk in the population.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 13:27:12 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1506 label Biography information for Andrew Gwynne

61314

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cystic Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will review prescription charges for adults with cystic fibrosis.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	200281
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>In 2010, responding to Professor Sir Ian Gilmore's review into extending entitlement to free prescriptions to all those with a long-term condition, the Government made clear that in light of the challenging financial context, no changes would be made to the current list of exemptions. Prescription charges in England raise valuable income, in the region of £450 million each year, which helps the National Health Service to maintain vital services for patients.</p><p> </p><p>The extensive system of exemption arrangements, including for those on low incomes who may struggle to pay for their prescriptions, which is in place means that around 90% of all prescription items are already dispensed free of charge. Prescription Prepayment Certificates (PPCs) are also available for those who have to pay NHS prescription charges and need multiple prescriptions. This is the fifth year the cost of an annual certificate, and the third year the cost of a three month certificate, have been frozen. Both certificates will also remain at £104 and £29.10 respectively, next year. There is no limit to the number of items that can be obtained through a PPC. The annual certificate benefits anyone needing more than 12 items a year, and the three month certificate anyone needing more than three items in that three month period.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 13:38:11 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4124 label Biography information for Chi Onwurah

61324

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much NHS trusts have spent (a) on agency and contract staff and (b) on all staff in each financial year since 2009-10.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	200211
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>As part of the response to the issues in Mid-Staffordshire hospital, and following the recommendations of the Francis report, many trusts have increased agency spend in the short-term to protect patients and improve patient care. Over the longer term, a key objective for the NHS is to keep agency spend to a minimum, an increase in the number of permanent front-line staff is vital to both improving patient care and delivering value for money. The number of frontline clinical staff has increased by more than 16,300 since 2010.</p><p> </p><p>In 2013-14, NHS foundation trusts planned to spend £523 million on agency and contract staff and spent £1,373.0 million. NHS trusts spent £1,209.1 million, how much they planned to spend is not available.</p><p> </p><p>Sources: for NHS trusts – unaudited data in NHS trust summarisation schedules; for NHS foundation trusts – quarterly monitoring information.</p><p> </p><p>Plans are in place in Better Procurement to reduce by £450 million spend on agency and contract staff by the end of 2016.</p><p> </p><p>NHS Trusts spent £1,209.1 million on agency and contract staff n 2013/14.</p><p> </p><p>Source: Unaudited data in NHS Trust Summarisation Schedules.</p><p> </p><p>Amounts for 2009-10 to 2012-13 were not separately identified from other non-permanent staff.</p><p> </p><p>Spend by NHS Foundation Trusts on agency and contract staff is in the following table.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2009/10</p></td><td><p>764.1</p></td></tr><tr><td><p>2010/11</p></td><td><p>854.7</p></td></tr><tr><td><p>2011/12</p></td><td><p>907.0</p></td></tr><tr><td><p>2012/13</p></td><td><p>1,101.0</p></td></tr><tr><td><p>2013/14</p></td><td><p>1,373.0</p></td></tr></tbody></table><p><em> </em></p><p><em>Notes</em>: For 2009/10 - 2012/13 actual figures are based on gross staff costs as per notes in the NHS FT consolidated accounts. The figures from the consolidated accounts may differ to the Board reports due to adjustments made on redundancy, early retirement, capitalisation of staff costs and costs of R&amp;D staff. 2013/14 figures are from quarterly monitoring information.</p><p> </p><p>Information available about spend on all staff is set out in the tables below.</p><p> </p><p>NHS Trusts</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2009/10</p></td><td><p>18,225.1</p></td></tr><tr><td><p>2010/11</p></td><td><p>18,929.5</p></td></tr><tr><td><p>2011/12</p></td><td><p>19,839.5</p></td></tr><tr><td><p>2012/13</p></td><td><p>19,344.7</p></td></tr></tbody></table><p><em> </em></p><p><em>Source: NHS (England) Summarised Accounts 2009/10, 2010/11; NHS Trust Audited Summarisation Schedules 2011/12, 2012/13. </em></p><p><em> </em></p><p><em>Note: </em>Total staff costs for 2013/14 are not yet available.</p><p> </p><p>NHS Foundation Trusts</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2009/10</p></td><td><p>17,599.7</p></td></tr><tr><td><p>2010/11</p></td><td><p>19,442.9</p></td></tr><tr><td><p>2011/12</p></td><td><p>23,046.0</p></td></tr><tr><td><p>2012/13</p></td><td><p>24,709.0</p></td></tr><tr><td><p>2013/14</p></td><td><p>26,246.0</p></td></tr></tbody></table><p> </p><p><em>Notes</em>: For 2009/10 - 2012/13 actual figures are based on gross staff costs as per notes in the NHS FT consolidated accounts. The figures from the consolidated accounts may differ to the Board reports due to adjustments made on redundancy, early retirement, capitalisation of staff costs and costs of R&amp;D staff. 2013/14 figures are from quarterly monitoring information.</p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 200212 question first answered 16/06/2014 16:51:14 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4026 label Biography information for Liz Kendall

61325

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Temporary Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much NHS trusts (a) planned to spend and (b) spent on agency and contract staff in 2013-14.
tabling member constituency	Leicester West
tabling member printed	Liz Kendall
uin	200212
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>As part of the response to the issues in Mid-Staffordshire hospital, and following the recommendations of the Francis report, many trusts have increased agency spend in the short-term to protect patients and improve patient care. Over the longer term, a key objective for the NHS is to keep agency spend to a minimum, an increase in the number of permanent front-line staff is vital to both improving patient care and delivering value for money. The number of frontline clinical staff has increased by more than 16,300 since 2010.</p><p> </p><p>In 2013-14, NHS foundation trusts planned to spend £523 million on agency and contract staff and spent £1,373.0 million. NHS trusts spent £1,209.1 million, how much they planned to spend is not available.</p><p> </p><p>Sources: for NHS trusts – unaudited data in NHS trust summarisation schedules; for NHS foundation trusts – quarterly monitoring information.</p><p> </p><p>Plans are in place in Better Procurement to reduce by £450 million spend on agency and contract staff by the end of 2016.</p><p> </p><p>NHS Trusts spent £1,209.1 million on agency and contract staff n 2013/14.</p><p> </p><p>Source: Unaudited data in NHS Trust Summarisation Schedules.</p><p> </p><p>Amounts for 2009-10 to 2012-13 were not separately identified from other non-permanent staff.</p><p> </p><p>Spend by NHS Foundation Trusts on agency and contract staff is in the following table.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2009/10</p></td><td><p>764.1</p></td></tr><tr><td><p>2010/11</p></td><td><p>854.7</p></td></tr><tr><td><p>2011/12</p></td><td><p>907.0</p></td></tr><tr><td><p>2012/13</p></td><td><p>1,101.0</p></td></tr><tr><td><p>2013/14</p></td><td><p>1,373.0</p></td></tr></tbody></table><p><em> </em></p><p><em>Notes</em>: For 2009/10 - 2012/13 actual figures are based on gross staff costs as per notes in the NHS FT consolidated accounts. The figures from the consolidated accounts may differ to the Board reports due to adjustments made on redundancy, early retirement, capitalisation of staff costs and costs of R&amp;D staff. 2013/14 figures are from quarterly monitoring information.</p><p> </p><p>Information available about spend on all staff is set out in the tables below.</p><p> </p><p>NHS Trusts</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2009/10</p></td><td><p>18,225.1</p></td></tr><tr><td><p>2010/11</p></td><td><p>18,929.5</p></td></tr><tr><td><p>2011/12</p></td><td><p>19,839.5</p></td></tr><tr><td><p>2012/13</p></td><td><p>19,344.7</p></td></tr></tbody></table><p><em> </em></p><p><em>Source: NHS (England) Summarised Accounts 2009/10, 2010/11; NHS Trust Audited Summarisation Schedules 2011/12, 2012/13. </em></p><p><em> </em></p><p><em>Note: </em>Total staff costs for 2013/14 are not yet available.</p><p> </p><p>NHS Foundation Trusts</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>£ million</p></td></tr><tr><td><p>2009/10</p></td><td><p>17,599.7</p></td></tr><tr><td><p>2010/11</p></td><td><p>19,442.9</p></td></tr><tr><td><p>2011/12</p></td><td><p>23,046.0</p></td></tr><tr><td><p>2012/13</p></td><td><p>24,709.0</p></td></tr><tr><td><p>2013/14</p></td><td><p>26,246.0</p></td></tr></tbody></table><p> </p><p><em>Notes</em>: For 2009/10 - 2012/13 actual figures are based on gross staff costs as per notes in the NHS FT consolidated accounts. The figures from the consolidated accounts may differ to the Board reports due to adjustments made on redundancy, early retirement, capitalisation of staff costs and costs of R&amp;D staff. 2013/14 figures are from quarterly monitoring information.</p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 200211 question first answered 16/06/2014 16:51:15 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4026 label Biography information for Liz Kendall

61349

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answer to the hon. Member for Suffolk Coastal of 8 January 2014, Official Report, column 265W, on general practitioners: Suffolk, how much his Department spent funding each general practice in England in 2012-13; and what spending type and GP Practice code applies in each case.
tabling member constituency	Fareham
tabling member printed	Mr Mark Hoban
uin	200278
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>The requested information is not collected centrally. The Investment in General Practice report published by the Health and Social Care Information Centre includes the investment in General Practice and the reimbursement of drugs dispensed in General Practices at national level. A copy has been placed in the Library.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 16:23:46 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name PQ200278 - Lib Doc - Report.pdf title Investment in General Practice
tabling member	1414 label Biography information for Mr Mark Hoban

61366

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Armed Forces: In Vitro Fertilisation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons the policy of NHS England on the number of cycles of IVF it provides to armed forces personnel is to provide fewer than the number recommended by National Institute for Health and Care Excellence.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	200338
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>NHS England has a number of interim policies in place, including the policy for the provision of in vitro fertilisation (IVF) for Armed Forces personnel.</p><p> </p><p>A review of the interim policy in relation to the provision of IVF for Armed Forces personnel has recently been undertaken. Following detailed costing of a move to the levels recommended in the National Institute for Health and Care Excellence guideline, it was agreed in May 2014 to increase the number of cycles of IVF to three if clinically appropriate and if eligibility criteria are met.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 16/06/2014 16:13:06 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

61367

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Fertility
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the forthcoming National Institute for Health and Care Excellence quality standard on fertility will be considered for a CCG Outcome Indicator.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	200339
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet published its final quality standard on fertility. NICE's Clinical Commissioning Group Outcomes Indicator Set (CCGOIS) Advisory Committee makes recommendations on potential indicators derived from its published guidance and quality standards for inclusion in the CCGOIS which are then considered by NHS England.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 16/06/2014 15:24:53 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

61368

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Melanotan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the (a) prevalence and (b) effect of the sale of the unlicensed drug Melanotan (i) online and (ii) in shops.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	200340
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>There are strict legal controls governing the sale and supply of medicinal products in the United Kingdom.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) considers Melanotan products to be medicinal products within the meaning of the Human Medicines Regulations 2012 and as such, the manufacture, sale and supply are subject to UK regulatory control. No Melanotan product holds a marketing authorisation (product licence) for use in the UK and consequently advertising and sale or supply would be in breach of regulatory requirements.</p><p> </p><p>The MHRA is aware that Melanotan is being sold through some outlets such as gyms and beauty salons and is available more widely on the Internet through certain websites.</p><p> </p><p>During the past 12 months, the MHRA has worked with Internet Service Providers in the UK and abroad to suspend more than 100 websites illegally trading in Melanotan.</p><p> </p><p>The MHRA issues regular warnings to the public about the dangers involved in the use of unlicensed medicines, including Melanotan and officials have participated in Press campaigns and specific media coverage of the problem.</p><p> </p><p>As of 12 June 2014, the MHRA has received a total of 22 reports of Adverse Drug Reactions associated with the use of Melanotan (product names Melanotan I, Melanotan II and Ubertan), describing a total of 93 adverse reactions. However, it is important to note that the reporting of a suspected adverse reaction does not necessarily mean it is related to the drug.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 13:47:09 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4036 label Biography information for Luciana Berger

61369

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health: Business
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of the number of companies who have signed up to one or more pledges set out in the Responsibility Deal; and what estimate he has made of the proportion of those companies which are meeting all of the pledges they have signed up to.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	200341
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>675 partners are currently signed up the Responsibility Deal. Details of these partners, the pledges they are committed to taking action on and their annual updates are available in full on the Responsibility Deal website at:</p><p> </p><p>https://responsibilitydeal.dh.gov.uk/partners/</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 16/06/2014 14:20:28 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger